CAR T-Cell Therapy
Helping families understand how immunotherapy fights cancer cells
Project Background
Chimeric antigen receptor (CAR) T-cell therapy uses gene-edited lymphocytes to bind to specific cancer cell antigens. It can be used to treat leukemia and lymphoma that do not respond to other therapies. A children’s research hospital asked us to help explain this treatment to families.
Our Work
We designed anthropomorphized cell characters grounded in scientific accuracy. In the sequence of images, the T-Cell character is enhanced with new chimeric antigen receptor (CAR) arms that help it grab and destroy cancer cells.
Results
The images are embedded with an article on the patient education website of the children’s research hospital.
